Treacher Collins Syndrome Associated with Disproportionate Nervous System,Cardiovascular,Otologic Complications Among 1,114 Patients

Abstract

Objective

To compare the rates of selected nervous system, cardiovascular, and otologic abnormalities in patients with and without Treacher Collins Syndrome (TCS).

Design

Retrospective TriNetX platform cohort study.

Setting

Aggregated and deidentified electronic health record (EHR) data from across the United States.

Patients, Participants

Patients with TCS (n = 1,114) and a propensity matched control cohort without TCS (n = 1,114 matched from n = 110,368,585).

Main Outcome Measured

Prevalence and relative risk (RR) of selected diagnoses in a propensity-matched cohort.

Results

The RR of congenital malformations of the circulatory system in patients with TCS was 8.5 (95% CI 4.44-16.28). Patients with TCS also had higher rates of otologic abnormalities including conductive hearing loss (RR 44, 95% CI 24-83) and nervous system disorders including movement disorders (RR 2.60, 95% CI 1.27-5.50) and recurrent seizures (RR 4.2, 95% CI 2.12-8.33).

Conclusions

We found a significantly elevated risk in TCS patients within all three systems. We postulate that the nervous system effects may be the result of one of the TCS-linked genes, for which a mutation has also been associated with progressive ataxia, cerebellar atrophy, hypomyelination, and seizures. As the previously-identified causal genes influence neural crest cells that form the head and face, these cells may also populate cardiac structures, resulting in cardiovascular abnormalities. Finally, the characteristic craniofacial abnormalities identified in TCS impair hearing and are associated with increased risk of otitis media. Our findings may help researchers to hypothesize the function of the genes underlying TCS, as well as to inform the care of affected individuals.

Get full access to this article

View all access options for this article.

References

Plomp

van Lieshout

MJS

Joosten

KFM

, et al. Treacher Collins Syndrome: A Systematic Review of Evidence-Based Treatment and Recommendations. Plast Reconstr Surg. Jan 2016;137(1):191-204. doi:https://doi.org/10.1097/PRS.0000000000001896

Teber

Gillessen-Kaesbach

Fischer

, et al. Genotyping in 46 patients with tentative diagnosis of Treacher Collins syndrome revealed unexpected phenotypic variation. Eur J Hum Genet. Nov 2004;12(11):879‐90. doi:https://doi.org/10.1038/sj.ejhg.5201260

Katsanis

Jabs

EW.

Treacher Collins Syndrome. In: Adam

Everman

Mirzaa

, et al, eds. GeneReviews((R)). 1993.

Trainor

Dixon

MJ.

Treacher Collins syndrome: etiology, pathogenesis and prevention. Eur J Hum Genet. Mar 2009;17(3):275‐83. doi:https://doi.org/10.1038/ejhg.2008.221

Paljarvi

Forton

Luciano

Herttua

Fazel

Analysis of Neuropsychiatric Diagnoses After Montelukast Initiation. JAMA Netw Open. May 2 2022;5(5):e2213643. doi:https://doi.org/10.1001/jamanetworkopen.2022.13643

Taquet

Dercon

Luciano

Geddes

Husain

Harrison

PJ.

Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. Sep 2021;18(9):e1003773. doi:https://doi.org/10.1371/journal.pmed.1003773

David

Yates Sinn

DP.

Classification, Diagnosis, and Etiology of Craniofacial Deformities. Maxillofacial Surgery (Third Edition). 2017:803-834.

Kraoua

Karkar

Drissi

, et al. Novel POLR1C mutation in RNA polymerase III-related leukodystrophy with severe myoclonus and dystonia. Mol Genet Genomic Med. Sep 2019;7(9):e914. doi:https://doi.org/10.1002/mgg3.914

Gauquelin

Cayami

Sztriha

, et al. Clinical spectrum of POLR3-related leukodystrophy caused by biallelic POLR1C pathogenic variants. Neurol Genet. Dec 2019;5(6):e369. doi:https://doi.org/10.1212/NXG.0000000000000369

10.

Thiffault

Wolf

Forget

, et al. Recessive mutations in POLR1C cause a leukodystrophy by impairing biogenesis of RNA polymerase III. Nat Commun. Jul 7 2015;6:7623. doi:https://doi.org/10.1038/ncomms8623

11.

Panamonta

Chaikitpinyo

Wongswadiwat

Chan-on

Panamonta

. Cardiovascular Malformations in Patients with Treacher Collins Syndrome: A Systematic Review. J Med Assoc Thai. 2018:101:221.

12.

Beaumont

Dunaway

Padwa

Forrest

Koudstaal

Caron

Extracraniofacial anomalies in Treacher Collins syndrome: A multicentre study of 248 patients. Int J Oral Maxillofac Surg. Nov 2021;50(11):1471‐1476. doi:https://doi.org/10.1016/j.ijom.2021.03.001

13.

Vincent

Genevieve

Ostertag

, et al. Treacher Collins syndrome: a clinical and molecular study based on a large series of patients. Genet Med. Jan 2016;18(1):49‐56. doi:https://doi.org/10.1038/gim.2015.29

14.

Passos-Bueno

Ornelas

Fanganiello

RD.

Syndromes of the first and second pharyngeal arches: A review. Am J Med Genet A. Aug 2009;149A(8):1853‐9. doi:https://doi.org/10.1002/ajmg.a.32950

15.

Marres

HA.

Hearing loss in the Treacher-Collins syndrome. Adv Otorhinolaryngol. 2002;61:209‐15. doi:https://doi.org/10.1159/000066811

16.

Bluestone CD. Pathogenesis of otitis media: role of eustachian tube. The Pediatric Infectious Disease Journal. 1996;15(4):281‐291.

17.

Lund

Vestergaard

Christensen

Uldbjerg

Becher

Prenatal diagnosis of Nager syndrome in a 12-week-old fetus with a whole gene deletion of SF3B4 by chromosomal microarray. Eur J Med Genet. Jan 2016;59(1):48‐51. doi:https://doi.org/10.1016/j.ejmg.2015.12.001

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.01 MB